IRVINE, Calif. and NEW YORK, June 8,
2016 /PRNewswire/ -- The Allergan Foundation, a
U.S.-based private charitable foundation endowed by Allergan plc,
today announced that it will provide a three-year, $300,000 scholarship commitment to support The
Jed Foundation's JED Campus Program, a nationwide initiative
designed to empower schools with customized support to enhance
student mental health and improve substance abuse and suicide
prevention efforts. The scholarship fund was created to ensure that
schools with limited resources can access the JED Campus Program
and build effective and sustainable mental health safety nets to
support student well-being.
The JED Campus Program helps participating colleges and
universities assess and improve their mental health, substance
abuse, and suicide prevention policies and programming. Beyond
supporting schools in these critical, under-resourced areas, this
initiative also brings the importance of mental health to the
forefront of national attention.
"The Allergan Foundation is proud to support the critical work
of The Jed Foundation in advancing initiatives that help support
the mental health and well-being of America's college students,"
said Gwyn Grenrock, Executive
Director, The Allergan Foundation. "Through this commitment to the
JED Campus Program, we will have a direct impact on helping to
create a positive atmosphere for addressing mental health issues
and fostering well-being across many of America's college campuses
for hundreds of thousands of students who need support during a
very dynamic, challenging time in their lives."
"We are grateful to The Allergan Foundation for its generous
support to enhance critical mental health programming and emotional
health resources for more than 500,000 students nationwide," said
John MacPhee, Executive Director and
CEO, The Jed Foundation. "The new scholarship fund will enable more
than 50 additional universities to participate in the JED Campus
Program, and we are hopeful that, as the scholarship fund grows, we
will be able to continue expanding access and capabilities to help
build safer, healthier campus communities across the country."
About the JED Campus Program
By becoming a member of the JED Campus Program, a school
demonstrates a commitment to the emotional well-being of its
students. Participating schools embark on a multi-year strategic
partnership with The Jed Foundation to assess and enhance the work
that is already being done, and also help to create positive,
lasting systemic change in the campus community.
Over the course of their participation in the program, JED
Campus schools receive:
- Support in the development of an interdisciplinary, campus-wide
team that includes senior leadership to steer this work at their
university
- An in-depth, confidential self-assessment survey at the
beginning of the program and then again after three years,
assessing mental health promotion and substance abuse and suicide
prevention efforts
- Customized feedback reports created by JED's clinical team
after each survey identifying successes and opportunities for
enhancement
- An onsite meeting with a JED expert to develop a strategic plan
tailored to a school's individual needs that will serve as a
roadmap to implement enhancements over the course of the
program
- Ongoing support from a dedicated JED Campus Manager who
provides consultation, guidance and resources to help each school
achieve its goals
- Membership in a nationwide Learning Community – a network of
JED Campus Program schools that share advice and experiences as
well as presentations/discussions on specific topics of interest
that emerge from JED's work with the schools
- The JED Campus Program membership seal to signify the school's
commitment to student mental health
About the Allergan Foundation
The Allergan Foundation is a U.S.-based, private charitable
foundation committed to providing a lasting and positive impact in
the communities in which Allergan plc employees live and work. In
addition to allocating resources primarily on health and human
services, the Foundation conducts grant making in support of civic
and community programs, education and the arts. Since its inception
in 1998, The Allergan Foundation has distributed over $60 million to a wide variety of philanthropic
pursuits – improving lives, elevating communities.
About The Jed Foundation
The Jed Foundation (JED) is a national nonprofit that exists to
protect the emotional health of our country's 40 million high
school and college students and reduce their risks of substance
abuse and suicide. We're partnering with high schools and colleges
to help strengthen their mental health, substance abuse and suicide
prevention programming and systems. We're developing accessible
resources and powerful partnerships so that students have the
support they need, when and how they need it, and we're encouraging
awareness, understanding and action around mental health
issues.
Learn more at www.jedfoundation.org. Check out our programs
including: JED Campus Program (www.thecampusprogram.org), ULifeline
(www.ulifeline.org), Half of Us (www.halfofus.com), Love is Louder
(www.loveislouder.com), and Transition Year
(www.transitionyear.org).
Follow JED on social
media: Twitter | Facebook | Instagram | YouTube | LinkedIn
About Allergan
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a unique, global
pharmaceutical company and a leader in a new industry model –
Growth Pharma. Allergan is focused on developing,
manufacturing and commercializing innovative branded
pharmaceuticals, high-quality generic and over-the-counter
medicines and biologic products for patients around the world.
Allergan markets a portfolio of best-in-class products that
provide valuable treatments for the central nervous system, eye
care, medical aesthetics, gastroenterology, women's health,
urology, cardiovascular and anti-infective therapeutic categories,
and operates the world's third-largest global generics business,
providing patients around the globe with increased access to
affordable, high-quality medicines. Allergan is an industry leader
in research and development, with one of the broadest development
pipelines in the pharmaceutical industry and a leading position in
the submission of generic product applications globally.
With commercial operations in approximately 100 countries,
Allergan is committed to working with physicians, healthcare
providers and patients to deliver innovative and meaningful
treatments that help people around the world live longer, healthier
lives.
For more information, visit Allergan's website at
www.Allergan.com.
Forward-Looking Statement
Statements contained in this press release that refer to future
events or other non-historical facts are forward-looking statements
that reflect Allergan's current perspective of existing trends and
information as of the date of this release. Except as expressly
required by law, Allergan disclaims any intent or obligation to
update these forward-looking statements. Actual results may differ
materially from Allergan's current expectations depending upon a
number of factors affecting Allergan's business. These factors
include, among others, the difficulty of predicting the timing or
outcome of FDA approvals or actions, if any; the impact of
competitive products and pricing; market acceptance of and
continued demand for Allergan's products; difficulties or delays in
manufacturing; and other risks and uncertainties detailed in
Allergan's periodic public filings with the Securities and Exchange
Commission, including but not limited to Allergan's Annual Report
on Form 10-K for the year ended December 31,
2015 and Quarterly Report on Form 10-Q for the quarter ended
March 31, 2016 (certain of such
periodic public filings having been filed under the "Actavis plc"
name). Except as expressly required by law, Allergan disclaims any
intent or obligation to update these forward-looking
statements.
CONTACTS:
ALLERGAN
Mark Marmur
(862) 261-7558
JED FOUNDATION
Jon Colucci
Makovsky for The Jed Foundation
(212) 508-9646
Logo -
http://photos.prnewswire.com/prnh/20160607/376578LOGO
Logo -
http://photos.prnewswire.com/prnh/20150612/222796LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/the-allergan-foundation-and-the-jed-foundation-announce-three-year-300000-scholarship-fund-to-support-jed-campus-program-300281460.html
SOURCE The Allergan Foundation